Svetlana Nikic, Founder of Precision Oncology Consulting, shared a post on LinkedIn:
“Is your company developing an innovative precision diagnostics that could improve the lives of cancer patients?
If so, your ultimate goal is likely to see it adopted as part of standard of care testing. That journey requires more than great science — it demands a clear market access strategy and early engagement with the right stakeholders.
Also, keep in mind that across Europe, securing reimbursement can take 2–6 years so the sooner you plan, the smoother the path to adoption!
To support companies at this stage, I offer off-the-shelf insights covering funding flows, key stakeholders, reimbursement processes, cancer statistics, and national cancer initiatives across Spain, Germany, France, and Italy. These reports also include recommendations tailored for manufacturers to strengthen their market access strategies — ready to use and far more cost-effective than a custom project.
Please visit the website or message me directly for more information.”
More Posts Featuring Svetlana Nikic.